Grant

A Phase III, Randomized, Placebo-Controlled, Double-Blind, Multi-Center, International Study of Durvalumab with Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients...

Sponsored by Astrazeneca

Active

$1.3M Funding

1 People

External

Related Topics

immunotherapy, radiation therapy, cancer treatment, clinical trial

People

Charles Hsu
Principal Investigator (PI)
Radiation Oncology﹒Associate Professor, Radiation Oncology - (Clinical Scholar Track)